| Literature DB >> 27002850 |
Abhishek K Sah1, Preeti K Suresh1.
Abstract
Eye is a vital organ of our body and any complication not only poses the risk of serious medical condition but also economic burden on the individual. Timolol maleate is one of the preferable therapeutic agents for the management of glaucoma. Globally, eye drops are among the most common and popular conventional formulations, but they are also associated with some limitations in terms of therapeutic response, bioavailability, dosing frequency and poor patient compliance. Present paper gives an overview of the drug delivery systems developed for management of glaucoma, advances and novel approaches with special emphasis on timolol drug delivery.Entities:
Keywords: Eye; glaucoma; ocular; ocular drug delivery; ophthalmic; timolol; topical
Mesh:
Substances:
Year: 2016 PMID: 27002850 DOI: 10.3109/21691401.2016.1160917
Source DB: PubMed Journal: Artif Cells Nanomed Biotechnol ISSN: 2169-1401 Impact factor: 5.678